EDEN - The Natural Solution

News Archive

2012

04 December

Director's dealing

04 December

Appointment of director

29 November

Change of adviser

27 November

Second Notice of Acceptance expands patent protection in Australia

09 November

Notice of Acceptance of patent in Australia

17 October

EU registration milestone reached

27 September

Interim Results for the six months ended 30 June 2012

13 September

Update on Certis Europe

14 June

Director's Dealing

12 June

Results of Annual General Meeting

12 June

AGM Statement and Business Update

21 May

Publication of Annual Report and AGM Details

17 May

Holding(s) in Company

17 May

Grant of Patent

11 May

Admission to Trading on AIM

10 May

Cessation of Trading on PLUS Markets and Admission to Trading on AIM

08 May

Publication of Admission Document

01 May

Holding(s) in Company

26 April

Schedule 1 update - Eden Research plc

26 April

Conversion of all Outstanding Loans, Issue of Equity and Directors' Interests

26 April

Grant of patent in Australia

16 April

Preliminary results

13 April

Notice of preliminary results and AIM update

19 March

Agreement with Phytalexin Limited for head-lice product

24 February

Agreement with Xeda International

22 February

Memorandum of Understanding with FMC Corporation

22 February

Appointment of Zeus Capital as advisor

06 January

TR-1: Notification of Major Interest in Shares

06 January

Teva Animal Health, Inc. exercises option that provides exclusive license rights with Eden